利润表（睿智医药）
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 一、营业总收入(元) | 718,525,731.65 | 465,164,579.93 | 234,594,741.64 | 1,138,365,803.00 | 846,178,408.68 | 557,454,592.06 | 268,658,644.91 |
| 营业收入(元) | 718,525,731.65 | 465,164,579.93 | 234,594,741.64 | 1,138,365,803.00 | 846,178,408.68 | 557,454,592.06 | 268,658,644.91 |
| 二、营业总成本(元) | 774,216,447.70 | 525,102,424.42 | 263,463,408.41 | 1,198,434,734.47 | 879,735,250.88 | 574,957,925.42 | 300,284,445.11 |
| 营业成本(元) | 580,392,041.96 | 389,334,679.48 | 193,136,476.58 | 843,125,473.18 | 635,860,315.07 | 418,761,764.00 | 192,281,330.81 |
| 研发费用(元) | 45,275,069.93 | 32,166,317.85 | 16,901,112.25 | 77,468,257.76 | 58,852,322.35 | 37,318,323.92 | 20,950,769.76 |
| 营业税金及附加(元) | 4,077,279.77 | 3,136,583.56 | 970,462.10 | 5,669,744.54 | 3,094,058.05 | 2,779,525.45 | 276,531.67 |
| 销售费用(元) | 28,332,227.32 | 21,080,953.73 | 10,997,471.42 | 45,596,590.27 | 33,629,661.76 | 21,703,782.49 | 10,187,537.94 |
| 管理费用(元) | 108,034,303.98 | 77,678,203.20 | 39,205,533.26 | 212,549,928.34 | 142,859,557.00 | 94,050,705.59 | 60,003,484.81 |
| 财务费用(元) | 8,105,524.74 | 1,705,686.60 | 2,252,352.80 | 14,024,740.38 | 5,439,336.65 | 343,823.97 | 16,584,790.12 |
| 其中：利息费用(元) | 2,911,402.21 | 2,139,821.81 | 1,061,819.90 | 31,299,155.13 | 4,286,079.48 | 3,380,987.14 | 2,609,317.74 |
| 其中：利息收入(元) | 7,167,883.24 | 4,664,618.03 | 2,278,712.70 | 14,793,659.48 | 11,406,614.81 | 8,663,717.80 | 7,068,700.94 |
| 三、其他经营收益 | |||||||
| 加：公允价值变动收益(元) | 1,648.56 | - | - | - | -364,949.26 | -249,216.59 | - |
| 加：投资收益(元) | 7,301,977.95 | 2,500,977.33 | 1,727,374.35 | -922,396.63 | 10,264,158.92 | 8,230,937.51 | 3,280,955.00 |
| 其中：对联营企业和合营企业的投资收益(元) | 7,072,940.40 | 2,354,931.98 | 1,719,000.61 | -1,531,254.31 | 9,701,571.38 | 7,760,163.90 | 3,107,725.19 |
| 资产处置收益(元) | 3,621,788.88 | 48,133.97 | - | -412.39 | -1,546,018.11 | -13,586.75 | - |
| 资产减值损失(元) | -13,627,814.85 | -3,382,513.36 | -1,936,377.65 | -877,869,899.00 | -2,844,626.93 | -2,791,547.50 | -1,523,226.08 |
| 信用减值损失(元) | -14,756,509.91 | -11,877,023.49 | 272,295.47 | -6,073,572.70 | -1,351,565.11 | -3,089,257.10 | -443,594.50 |
| 其他收益(元) | 6,591,864.40 | 2,975,994.68 | 1,536,809.63 | 8,571,490.29 | 4,592,010.91 | 3,578,659.00 | 1,903,168.29 |
| 四、营业利润(元) | -66,557,761.02 | -69,672,275.36 | -27,268,564.97 | -936,363,721.90 | -24,807,831.78 | -11,837,344.79 | -28,408,497.49 |
| 加：营业外收入(元) | 29,117.39 | 20,154.16 | 67,985.42 | 815,880.00 | 319,048.31 | 224,037.24 | 121,847.23 |
| 减：营业外支出(元) | 510,060.41 | 405,325.86 | 239,553.36 | 4,218,098.40 | 65,623.55 | 60,377.30 | 317.30 |
| 五、利润总额(元) | -67,038,704.04 | -70,057,447.06 | -27,440,132.91 | -939,765,940.30 | -24,554,407.02 | -11,673,684.85 | -28,286,967.56 |
| 减：所得税费用(元) | -5,256,354.55 | -7,077,244.96 | -1,940,382.03 | -22,826,973.86 | 6,914,192.78 | 3,491,359.43 | -3,113,174.84 |
| 六、净利润(元) | -61,782,349.49 | -62,980,202.10 | -25,499,750.88 | -916,938,966.44 | -31,468,599.80 | -15,165,044.28 | -25,173,792.72 |
| (一)按经营持续性分类 | |||||||
| 持续经营净利润(元) | -61,782,349.49 | -62,980,202.10 | -25,499,750.88 | -916,938,966.44 | -31,468,599.80 | -15,165,044.28 | -25,173,792.72 |
| (二)按所有权归属分类 | |||||||
| 归属于母公司股东的净利润(元) | -61,667,008.36 | -62,906,492.74 | -25,460,550.66 | -916,752,668.84 | -31,322,915.93 | -15,095,685.76 | -25,145,108.24 |
| 少数股东损益(元) | -115,341.13 | -73,709.36 | -39,200.22 | -186,297.60 | -145,683.87 | -69,358.52 | -28,684.48 |
| 扣除非经常性损益后的净利润(元) | -69,041,288.84 | -64,038,605.87 | -28,009,409.29 | -919,319,253.44 | -38,771,246.00 | -22,198,829.94 | -29,246,265.24 |
| 七、每股收益 | |||||||
| 一、基本每股收益(元) | -0.12 | -0.13 | -0.05 | -1.84 | -0.06 | -0.03 | -0.05 |
| 二、稀释每股收益(元) | -0.12 | -0.13 | -0.05 | -1.84 | -0.06 | -0.03 | -0.05 |
| 八、其他综合收益(元) | -9,433,940.61 | -1,144,800.81 | 1,875,939.70 | 7,823,267.39 | 10,001,858.31 | 9,785,819.93 | -5,414,466.45 |
| 归属于母公司股东的其他综合收益(元) | -9,433,940.61 | -1,144,800.81 | 1,875,939.70 | 7,823,267.39 | 10,001,858.31 | 9,785,819.93 | -5,414,466.45 |
| 九、综合收益总额(元) | -71,216,290.10 | -64,125,002.91 | -23,623,811.18 | -909,115,699.05 | -21,466,741.49 | -5,379,224.35 | -30,588,259.17 |
| 归属于母公司所有者的综合收益总额(元) | -71,100,948.97 | -64,051,293.55 | -23,584,610.96 | -908,929,401.45 | -21,321,057.62 | -5,309,865.83 | -30,559,574.69 |
| 归属于少数股东的综合收益总额(元) | -115,341.13 | -73,709.36 | -39,200.22 | -186,297.60 | -145,683.87 | -69,358.52 | -28,684.48 |
| 公告日期 | 2024-10-30 | 2024-08-30 | 2024-04-26 | 2024-04-26 | 2023-10-25 | 2023-08-29 | 2023-04-27 |
| 审计意见(境内) | 标准无保留意见 | ||||||
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
| 上市前/上市后 |
| 报表类型 |
| 一、营业总收入(元) |
| 营业收入(元) |
| 二、营业总成本(元) |
| 营业成本(元) |
| 研发费用(元) |
| 营业税金及附加(元) |
| 销售费用(元) |
| 管理费用(元) |
| 财务费用(元) |
| 其中：利息费用(元) |
| 其中：利息收入(元) |
| 三、其他经营收益 |
| 加：公允价值变动收益(元) |
| 加：投资收益(元) |
| 其中：对联营企业和合营企业的投资收益(元) |
| 资产处置收益(元) |
| 资产减值损失(元) |
| 信用减值损失(元) |
| 其他收益(元) |
| 四、营业利润(元) |
| 加：营业外收入(元) |
| 减：营业外支出(元) |
| 五、利润总额(元) |
| 减：所得税费用(元) |
| 六、净利润(元) |
| (一)按经营持续性分类 |
| 持续经营净利润(元) |
| (二)按所有权归属分类 |
| 归属于母公司股东的净利润(元) |
| 少数股东损益(元) |
| 扣除非经常性损益后的净利润(元) |
| 七、每股收益 |
| 一、基本每股收益(元) |
| 二、稀释每股收益(元) |
| 八、其他综合收益(元) |
| 归属于母公司股东的其他综合收益(元) |
| 九、综合收益总额(元) |
| 归属于母公司所有者的综合收益总额(元) |
| 归属于少数股东的综合收益总额(元) |
| 公告日期 |
| 审计意见(境内) |
| 原始财报文件下载 |
Showing 1 to 44 of 44 entries